BA
LUNG icon

Bridgewater Associates’s Pulmonx LUNG Stock Holding History

Bridgewater Associates’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-52,412
Closed -$873K – 895
2022
Q3 		$873K Buy
52,412
+557
+1% +$10.3K ﹤0.01% 716
2022
Q2 		$763K Buy
51,855
+11,068
+27% +$228K ﹤0.01% 841
2022
Q1 		$1.01M Buy
40,787
+11,227
+38% +$290K ﹤0.01% 798
2021
Q4 		$948K Sell
29,560
-1,792
-6% -$65.5K 0.01% 586
2021
Q3 		$1.13M Buy
+31,352
New +$1.23M 0.01% 499

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Bridgewater Associates's LUNG Position: Q4 2022 in Review

Bridgewater Associates sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 52,412 shares — an estimated $873K sold.

Bridgewater Associates first reported a position in LUNG in Q3 2021 and held it in 5 quarters. The position peaked at $1.13M in Q3 2021. 116 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

  • Bridgewater Associates reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
  • Bridgewater Associates sold 52,412 Pulmonx shares in Q4 2022, an estimated $873K.
  • Bridgewater Associates first reported a position in Pulmonx in Q3 2021 and held it in 5 quarters.
  • Bridgewater Associates's Pulmonx position peaked at $1.13M in Q3 2021.
  • 116 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on Bridgewater Associates's 13F filing for Q4 2022, filed 13 Feb 2023.